Celgene Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Celgene careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: April 20, 2019, 3:15 pm
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: April 20, 2019, 3:15 pm
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: April 20, 2019, 3:15 pm
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: April 20, 2019, 3:15 pm
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: April 20, 2019, 3:15 pm

Viewing page 1 of 74|Next Page

  Newsfeed | Subscribe  

Apr 18, 2019 (Euclid Infotech Ltd via COMTEX) -- Celgene Corporation announced that its stockholders have voted to approve the companys proposed combination with Bristol-Myers Squibb Company. ...
Posted: April 18, 2019, 1:26 pm
Law360 (April 17, 2019, 6:16 PM EDT) -- Celgene has asked a New Jersey federal court to stop Sun Pharma from moving forward with its generic version of the blockbuster cancer medication Revlimid until ...
Posted: April 17, 2019, 3:27 pm
Bristol-Myers Squibb (NYSE:BMY) has initiated an exchange offer for outstanding Celgene (NASDAQ:CELG) debt for up to $19.85B of new debt to be issued by BMY and cash. Last week, shareholders in ...
Posted: April 17, 2019, 5:37 am
Bristol-Myers Squibb Company BMY, -1.03% (“Bristol-Myers Squibb) announced today the commencement, in connection with its previously announced acquisition of Celgene Corporation CELG, -0.58% (“Celgene ...
Posted: April 17, 2019, 5:18 am
Sure, there was some drama along the way with Bristol-Myers Squibb's (NYSE: BMY) proposed acquisition of Celgene (NASDAQ: CELG). But it never made sense to bet against the deal. And now ...
Posted: April 16, 2019, 3:08 am

Viewing page 1 of 2|Next Page